Department of Health and Human Services
National Institutes of Health
Toggle navigation
Search
Home
About the Clinical Center
Clinical Trials & You
Participate in a Study
Referring a Patient
How to Search
Contact Us
Search the Studies
Go Back
Searched Result
59 Studies found from all possible combinations of your search terms. Select a protocol that you wish to review.
Please note that only the first 5 legal search words are being processed.
Protocol Number
Title
Protocol Status
Min-Max Age
Institute
Keywords
000235-CH
COLSIO Trial: Phase II Randomized, Controlled Trial of Colchicine to Suppress Inflammation and Improve Insulin Resistance in Adults and Adolescents with Obesity
Participants currently recruited/enrolled
12-125 Years
NICHD
Mass Index
000220-DK
Phase II Trial of the Combination of Alpha-lipoic Acid and Mirabegron in Women and in Men with Obesity
Recruitment has not started
18-65 Years
NIDDK
Mass Index
22-DK-0002
Effect of Ultra-processed versus Unprocessed Diets on Energy Metabolism
Participants currently recruited/enrolled
18-60 Years
NIDDK
Mass Index
20-H-0044
Pilot Study to Evaluate the Effect of Nicotinamide Riboside on Immune Activation in Psoriasis
Completed Study; data analyses ongoing
18-80 Years
NHLBI
Mass Index
19-CH-0051
Long-Term Follow-UP of Survivors of Pediatric Cushing Disease
Participants currently recruited/enrolled
2-90 Years
NICHD
Mass Index
18-H-0019
Effect of Dietary Omega-7 Palmitoleic Acid-Rich Oil on Lipoprotein Metabolism and Satiety in Adults
Participants currently recruited/enrolled
18-125 Years
NHLBI
Mass Index
18-D-0114
An Open Label Pilot Study of Denosumab Treatment for Fibrous Dysplasia
No longer recruiting/follow-up only
18-125 Years
NIDCR
Index Quantitative
18-AA-0047
Effects of Sucralose on Drug Absorption and Metabolism (The SweetMeds Study)
Clinical hold/Recruitment or enrollment suspended
18-60 Years
NIAAA
Mass Index
17-DK-0054
The Physiological Responses and Adaptation of Brown Adipose Tissue to Chronic Treatment with Beta3-Adrenergic Receptor Agonists
Participants currently recruited/enrolled
18-40 Years
NIDDK
Mass Index
17-CH-0014
Pilot Study of Mobile Attention Training in Overweight Female Adolescents
Participants currently recruited/enrolled
12-21 Years
NICHD
Mass Index
16-H-0085
Pilot Study to Evaluate the Effect of Fasting and Refeeding on T-Cell Fate
Completed Study; data analyses ongoing
21-37 Years
NHLBI
Mass Index
15-AG-0063
The Genetic and Epigenetic Signatures of Translational Aging Laboratory Testing (GESTALT)
Participants currently recruited/enrolled
20-125 Years
NIA
Mass Index
14-CC-0143
Sleep Disturbance and Relapse in Individuals with Alcohol Dependence: An Exploratory Mixed Methods Study
Completed Study; data analyses ongoing
18-125 Years
CC
Index Quantitative
13-HG-0158
Patient Perspectives and Simulated Clinical Interactions
Completed Study; data analyses ongoing
18-50 Years
NHGRI
Mass Index
11-CC-0120
Stereophotogrammetry of the Torso in Healthy Individuals and Patients with Scoliosis, Chest Wall Deformations, or Obesity
Completed Study; data analyses ongoing
2-125 Years
CC
Mass Index
09-DK-0097
Vitamin E Pharmacokinetics and Biomarkers in Normal and Obese Women
Completed Study; data analyses ongoing
18-55 Years
NIDDK
Mass Index
08-DK-N191
The Effects of Transcranial Direct Current Stimulation (TDCS) on Food Intake and Weight Loss
Participants currently recruited/enrolled
18-60 Years
NIDDK
Mass Index
08-DK-N140
Predicting Adaptive Thermogenesis
Completed Study; data analyses ongoing
18-60 Years
NIDDK
Mass Index
05-CH-0037
The Effects of Hydrocortisone, Melatonin, and Placebo on Symptoms of Jet Lag
Completed Study; data analyses ongoing
18-65 Years
NICHD
Mass Index
01-DK-N117
Family Investigation of Nephropathy and Diabetes (F.I.N.D.)
Clinical hold/Recruitment or enrollment suspended
18-125 Years
NIDDK
Index Trait
99-DK-0002
Diabetes and Heart Disease Risk in Blacks
Participants currently recruited/enrolled
18-70 Years
NIDDK
Mass Index
96-CH-0033
An Open, Randomized, Long-Term Clinical Trial of Flutamide, Testolactone, and Reduced Hydrocortisone Dose vs. Conventional Treatment of Children with Congenital Adrenal Hyperplasia
No longer recruiting/follow-up only
2-18 Years
NICHD
Mass Index
001074-CH
Characterization of Dysmorphology in Subjects with Creatine Transporter Deficiency
Participants currently recruited/enrolled
2-40 Years
NICHD
Trait
000906-I
A Phase 2 Randomized, Double-Blinded Cross-Over Design Study of the Early Metabolic Effects of Dolutegravir or Tenofovir Alefenamide in Healthy Volunteers
Recruitment has not started
18-55 Years
NIAID
Mass
000784-N
Assessing and Improving Quantitative Magnetic Resonance Imaging Metrics in Human Subjects
Participants currently recruited/enrolled
18-125 Years
NINDS
Quantitative
000748-DK
Analysis of the Utility of Polygenic Scores for Prediction of Incident Type 2 Diabetes Across Multiple Ancestry Groups
No longer recruiting/follow-up only
0-125 Years
NIDDK
Index
000682-AR
The Role of Anifrolumab in Improving Markers of Vascular Risk in Patients with Systemic Lupus Erythematosus
Recruitment has not started
18-80 Years
NIAMS
Index
000428-N
An Observational Study to Assess Clinical, Molecular and Imaging Biomarkers in Spinal and Bulbar Muscular Atrophy (SBMA)
Participants currently recruited/enrolled
18-125 Years
NINDS
Mass
000417-CC
Characterization of the Nociception Phenotype in Individuals with Intellectual Disability
Clinical hold/Recruitment or enrollment suspended
8-30 Years
CC
Quantitative
000411-CC
A Feasibility Pilot Study of a Virtual Education-Based Transition Intervention to Improve Transition Readiness in Adolescent and Young Adults with Congenital Adrenal Hyperplasia.
Recruitment has not started
16-22 Years
CC
Index
000237-C
Phase II Study of Intravenous and Intraperitoneal Paclitaxel and Oral Nilotinib for Peritoneal Carcinomatosis from Colorectal, Appendiceal, Small Bowel, Gastric, Ovarian, or Other Gynecologic Primary Cancer
Participants currently recruited/enrolled
18-125 Years
NCI
Index
000134-I
A Phase 1b, Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation Trial of Intravenous Zotatifin in Adults with Mild or Moderate Coronavirus Disease 2019 (COVID-19)
Participants currently recruited/enrolled
18-125 Years
NIAID
Quantitative
000051-N
NIH Investigative Deep Phenotyping Study of Gulf War Veteran Health (Project NIH IN-DEPTH)
Participants currently recruited/enrolled
48-70 Years
NINDS
Mass
000037-CC
Development and Evaluation of Techniques for Computer Aided Detection and Diagnosis from Existing Radiologic Images
No longer recruiting/follow-up only
0-125 Years
CC
Mass
20-N-0064
An observational study to assess clinical manifestations and biomarkers in amyotrophic lateral sclerosis type 4 and other inherited neurological disorders of RNA processing.
Participants currently recruited/enrolled
5-125 Years
NINDS
Mass
20-H-0080
Red Cell Half Life Determination in Patients with and without Sickle Cell Disease
Completed Study; data analyses ongoing
18-100 Years
NHLBI
Trait
20-H-0068
Venous Thrombosis Biomarkers in Sickle Cell Disease and Sickle Cell Trait
Participants currently recruited/enrolled
18-80 Years
NHLBI
Trait
19-AT-0089
Sensory Afferents for Deep Pressure Sensation
Completed Study; data analyses ongoing
18-50 Years
NCCIH
Mass
18-HG-0129
Reverse Phenotyping Core (RPC)
Enrolling by Invitation
4-125 Years
NHGRI
Trait
18-H-0146
Genotype -Phenotype Correlation of PKLR Variants with Pyruvate Kinase, 2,3-Diphosphglycerate and ATP Activities in Red Blood Cells of Patients with Sickle Cell Disease
Participants currently recruited/enrolled
18-80 Years
NHLBI
Trait
17-N-0031
Detailed Evaluation of the Neurophysiology of Surround Inhibition in the Human Motor Cortex
Completed Study; data analyses ongoing
18-70 Years
NINDS
Index
17-C-0048
Anti-CD30 CAR T Cells with Fully-human Binding Domains for Treating CD30-expressing Lymphomas Including Anaplastic Large Cell Lymphomas
Completed Study; data analyses ongoing
18-73 Years
NCI
Mass
16-I-0065
Screening for Alpha Globin Deletions
Participants currently recruited/enrolled
18-39 Years
NIAID
Trait
16-H-0132
CADASIL Disease Discovery
Completed Study; data analyses ongoing
18-100 Years
NHLBI
Index
15-I-0056
Collection of Plasma from Subjects that Recovered From or Were Vaccinated To Emerging Infectious Diseases
Enrolling by Invitation
18-70 Years
NIAID
Quantitative
15-AR-0060
The Role of PPAR-gamma Agonists in immunomodulation and Vascular Prevention in SLE (PPAR-SLE)
Completed Study; data analyses ongoing
18-99 Years
NIAMS
Index
14-AA-0181
NIAAA Natural History Protocol
Participants currently recruited/enrolled
18-100 Years
NIAAA
Trait
12-H-0110
An Open-label, Non-Randomized, Single-Arm Pilot Study to Evaluate the Effectiveness of Etidronate Treatment for Arterial Calcifications due to Deficiency in CD73 (ACDC)
Completed Study; data analyses ongoing
18-80 Years
NHLBI
Index
12-C-0160
Validation of the English Version of the Pain Interference Index and the Pain Rating Scale in Children, Adolescents, and Adults with Chronic Illness and their Parents
Participants currently recruited/enrolled
18-125 Years
NCI
Index
09-C-0005
Randomized Trial of Cladribine (CdA) with Simultaneous or Delayed Rituximab to Eliminate Hairy Cell Leukemia Minimal Residual Disease
Participants currently recruited/enrolled
18-125 Years
NCI
Quantitative
08-DK-0004
High Sensitivity Screening of Compound Libraries to Discover a Drug for the Treatment of Sickle Cell Disease
Participants currently recruited/enrolled
18-100 Years
NIDDK
Trait
07-DK-0077
Study of the Phenotype of Overweight and Obese Adults
Participants currently recruited/enrolled
18-100 Years
NIDDK
Trait
06-M-0214
PET Measurement of Regional Rates of Cerebral Protein Synthesis in Subjects with Fragile X Syndrome
Completed Study; data analyses ongoing
18-24 Years
NIMH
Quantitative
04-CC-0119
Biomarkers and Protein Mass Expression Profiles in Bronchoalveolar Lavage from Patients with Lung Infiltrates
Participants currently recruited/enrolled
3-99 Years
CC
Mass
03-M-0211
Family Study of Affective and Anxiety Spectrum Disorders
Participants currently recruited/enrolled
7-120 Years
NIMH
Trait
01-H-0122
Collection and Storage of Umbilical Cord Hematopoietic Stem Cells for Sickle Cell Disease Therapy
Participants currently recruited/enrolled
18-45 Years
NHLBI
Trait
01-H-0088
Determining the Prevalence and Prognosis of Secondary Pulmonary Hypertension in Adult Patients with Sickle Cell Anemia
Completed Study; data analyses ongoing
18-125 Years
NHLBI
Trait
96-H-0100
Role of Genetic Factors in the Pathogenesis of Lung Disease
Participants currently recruited/enrolled
2-90 Years
NHLBI
Quantitative
94-E-0165
Studies in the Natural History and Pathogenesis of Childhood-Onset and Adult-Onset Idiopathic Inflammatory Myopathies
Participants currently recruited/enrolled
2-100 Years
NIEHS
Mass